AIM: Analyzing the presentation of molecular subtypes of breast cancer that are
immunohistochemically detected in surgically treated patients at the Clinic for Thoracic and …

Background Recent reports suggest increase in estrogen receptor (ER), progesterone
receptor (PR) negative breast cancer yet little is known about histology or receptor status of …

Triple-negative breast cancer accounts for less than 20% of breast cancers overall, but is the
predominant subtype among carriers of mutations in BRCA1. However, few studies have …

Aim The objective is to report the correlation between pathology and molecular subtype
classifications of breast cancer in Tunisian women. Methods This retrospective study …

Breast cancer is heterogenous, with variable expression of the estrogen receptor (er),
progesterone receptor (pr), and human epidermal growth factor receptor 2 (her 2) …

Breast carcinoma may be classified into distinct molecular subtypes based on
immunohistochemical markers for estrogen, progesterone and Her-2/neu receptors. The aim …

Breast cancer is a heterogeneous disease that is affected by ethnicity of patients. According
to hormone receptor status and gene expression profiling, breast cancers are classified into …

According to the immunohistochemical test of estrogen receptor (ER), progesterone receptor
(PR) and human epidermal growth factor receptor-2 (Her-2), breast cancer can be divided …

Introducción: en los últimos años la cirugía conservadora se ha consolidado como un
procedimiento válido en el tratamiento de un determinado grupo de pacientes con cáncer …

High levels of androgen receptor (AR) are often indicative of recurrent, advanced, or
metastatic cancers. These conditions are also characterized by a high proliferative fraction. 5 …